Minimed
This article was originally published in The Gray Sheet
Executive Summary
Launches Model 407C infusion pump for general medication use following 510(k) clearance June 23. Similar to the firm's insulin infusion pumps and designed to deliver medications suitable for subcutaneous administration, the 407C represents diversification of the firm's technology to include disease states other than diabetes. MiniMed expects the device to be first used in connection with its alliance with United Therapeutics for the treatment of pulmonary hypertensionYou may also be interested in...
MiniMed Continuous Glucose Monitor Rollout Expanding To 30 Centers In Q4
Expanded roll-out of MiniMed's continuous glucose monitor system to twenty-one additional U.S. centers will be completed by the end of November, the firm says.
MiniMed Continuous Glucose Monitor Rollout Expanding To 30 Centers In Q4
Expanded roll-out of MiniMed's continuous glucose monitor system to twenty-one additional U.S. centers will be completed by the end of November, the firm says.
Urologix Targis BPH Procedure Kit Sales Growth Spurs 38% August Stock Gain
Increased procedure kit sales for use with Urologix' Targis microwave catheter-based system for treatment of benign prostatic hyperplasia helped give the Minneapolis firm's stock a 38% boost in August.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Medtech Insight?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: